Acute and subacute antidiabetic studies of ENP-9, a new 1,5-diarylpyrazole derivative.

Eduardo Hernández-VázquezSandra Young-PeraltaLitzia Cerón-RomeroSara García-JiménezSamuel Estrada-Soto

Published in: The Journal of pharmacy and pharmacology (2018)

ENP-9 showed significant antihyperglycaemic and antidiabetic properties and also was demonstrated to be safety in the studied doses, which might allow future studies for its potential development as antidiabetic agent.

Keyphrases

case control
liver failure
current status
acute respiratory distress syndrome
water soluble
mechanical ventilation